Magnesium and Blood Pressure: A Physiology-Based Approach

Advances in Chronic Kidney Disease

Volumn 25, Issue 3, 2018, Pages 244-250

  Schutten, Joëlle C ^a   Joosten, Michel M ^a   de Borst, Martin H ^a   Bakker, Stephan J L ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Blood pressure; Hypertension; Magnesium; Mechanism; Physiology

Indexed keywords

ATRIAL NATRIURETIC FACTOR; MAGNESIUM; NITRIC OXIDE; NORADRENALIN; OSTEOGENIC PROTEIN 1; TRANSIENT RECEPTOR POTENTIAL MELASTIN; UNCLASSIFIED DRUG;

ARTERIAL STIFFNESS; BLOOD PRESSURE REGULATION; BLOOD VESSEL CALCIFICATION; CARDIOVASCULAR FUNCTION; CLINICAL STUDY; HEART OUTPUT; HUMAN; HYPERCALCEMIA; HYPERPHOSPHATEMIA; HYPOMAGNESEMIA; INFLAMMATION; MAGNESIUM INTAKE; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; VASCULAR RESISTANCE; ADVERSE EVENT; BLOOD PRESSURE; CHRONIC KIDNEY FAILURE; DIET; HYPERTENSION; MAGNESIUM DEFICIENCY; PATHOPHYSIOLOGY; PHYSIOLOGY; RISK FACTOR;

BLOOD PRESSURE; CARDIAC OUTPUT; DIET; HUMANS; HYPERTENSION; MAGNESIUM; MAGNESIUM DEFICIENCY; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; VASCULAR RESISTANCE;

EID: 85047268048     PISSN: 15485595     EISSN: 15485609     Source Type: Journal    
DOI: 10.1053/j.ackd.2017.12.003     Document Type: Review

References (62)

1. World Health Organization (WHO). A global brief on hypertension. Available at: http://apps.who.int/iris/bitstream/10665/79059/1/WHO_DCO_WHD_2013.2_eng.pdf. Published 2013. Accessed August 3, 2017.
2. Whaley-Connell, A.T., Sowers, J.R., Stevens, L.A., et al. CKD in the United States: Kidney early evaluation program (KEEP) and national health and nutrition examination survey (NHANES) 1999-2004. Am J Kidney Dis 51:4 Suppl 2 (2008), S13–S20.
3. Houston, M.C., Harper, K.J., Potassium, magnesium, and calcium: their role in both the cause and treatment of hypertension. J Clin Hypertens (Greenwich) 10:7 Suppl 2 (2008), 3–11.
4. Rosanoff, A., Weaver, C.M., Rude, R.K., Suboptimal magnesium status in the United States: are the health consequences underestimated?. Nutr Rev 70:3 (2012), 153–164.
5. Volpe, S.L., Magnesium in disease prevention and overall health. Adv Nutr 4:3 (2013), 378S–383S.
6. Witteman, J.C., Willett, W.C., Stampfer, M.J., et al. A prospective study of nutritional factors and hypertension among US women. Circulation 80:5 (1989), 1320–1327.
7. Ascherio, A., Rimm, E.B., Giovannucci, E.L., et al. A prospective study of nutritional factors and hypertension among US men. Circulation 86:5 (1992), 1475–1484.
8. Peacock, J.M., Folsom, A.R., Arnett, D.K., Eckfeldt, J.H., Szklo, M., Relationship of serum and dietary magnesium to incident hypertension: the atherosclerosis risk in communities (ARIC) study. Ann Epidemiol 9:3 (1999), 159–165.
9. Han, H., Fang, X., Wei, X., et al. Dose-response relationship between dietary magnesium intake, serum magnesium concentration and risk of hypertension: a systematic review and meta-analysis of prospective cohort studies. Nutr J, 16(1), 2017, 26.
10. Nissensohn, M., Roman-Vinas, B., Sanchez-Villegas, A., Piscopo, S., Serra-Majem, L., The effect of the mediterranean diet on hypertension: a systematic review and meta-analysis. J Nutr Educ Behav 48:1 (2016), 42–53.e1.
11. Ndanuko, R.N., Tapsell, L.C., Charlton, K.E., Neale, E.P., Batterham, M.J., Dietary patterns and blood pressure in adults: a systematic review and meta-analysis of randomized controlled trials. Adv Nutr 7:1 (2016), 76–89.
12. Appel, L.J., Moore, T.J., Obarzanek, E., et al., DASH Collaborative Research Group. A clinical trial of the effects of dietary patterns on blood pressure. N Engl J Med 336:16 (1997), 1117–1124.
13. Taylor, E.N., Stampfer, M.J., Mount, D.B., Curhan, G.C., DASH-style diet and 24-hour urine composition. Clin J Am Soc Nephrol 5:12 (2010), 2315–2322.
14. Joosten, M.M., Gansevoort, R.T., Mukamal, K.J., et al. Urinary magnesium excretion and risk of hypertension: the prevention of renal and vascular end-stage disease study. Hypertension 61:6 (2013), 1161–1167.
15. Dyckner, T., Wester, P.O., Effect of magnesium on blood pressure. Br Med J (Clin Res Ed) 286:6381 (1983), 1847–1849.
16. Kass, L., Weekes, J., Carpenter, L., Effect of magnesium supplementation on blood pressure: a meta-analysis. Eur J Clin Nutr 66:4 (2012), 411–418.
17. Jee, S.H., Miller, E.R. 3rd, Guallar, E., Singh, V.K., Appel, L.J., Klag, M.J., The effect of magnesium supplementation on blood pressure: a meta-analysis of randomized clinical trials. Am J Hypertens 15:8 (2002), 691–696.
18. Zhang, X., Li, Y., Del Gobbo, L.C., et al. Effects of magnesium supplementation on blood pressure: a meta-analysis of randomized double-blind placebo-controlled trials. Hypertens (Dallas, Tex 1979) 68:2 (2016), 324–333.
19. Dibaba, D.T., Xun, P., Song, Y., Rosanoff, A., Shechter, M., He, K., The effect of magnesium supplementation on blood pressure in individuals with insulin resistance, prediabetes, or noncommunicable chronic diseases: a meta-analysis of randomized controlled trials. Am J Clin Nutr 106:3 (2017), 921–929.
20. Salyer, S.A., Parks, J., Barati, M.T., et al. Aldosterone regulates Na(+), K(+) ATPase activity in human renal proximal tubule cells through mineralocorticoid receptor. Biochim Biophys Acta 1833:10 (2013), 2143–2152.
21. Atarashi, K., Matsuoka, H., Takagi, M., Sugimoto, T., Magnesium ion: a possible physiological regulator of aldosterone production. Life Sci 44:20 (1989), 1483–1489.
22. Atarashi, K., Takagi, M., Matsuoka, H., Sugimoto, T., Effects of magnesium on changes in blood pressure and plasma aldosterone induced by angiotensin II. Am J Hypertens 3:6 Pt 1 (1990), 488–490.
23. Jin, K., Kim, T.H., Kim, Y.H., Kim, Y.W., Additional antihypertensive effect of magnesium supplementation with an angiotensin II receptor blocker in hypomagnesemic rats. Korean J Intern Med 28:2 (2013), 197–205.
24. Ginn, H.E., Cade, R., McCallum, T., Fregley, M., Aldosterone secretion in magnesium-deficient rats. Endocrinology 80:5 (1967), 969–971.
25. Solounias, B.M., Schwartz, R., The effect of magnesium deficiency on serum aldosterone in rats fed two levels of sodium. Life Sci 17:8 (1975), 1211–1217.
26. Resnick, L.M., Laragh, J.H., Sealey, J.E., Alderman, M.H., Divalent cations in essential hypertension. Relations between serum ionized calcium, magnesium, and plasma renin activity. N Engl J Med 309:15 (1983), 888–891.
27. Kojima, I., Kojima, K., Rasmussen, H., Effects of ANG II and K+ on Ca efflux and aldosterone production in adrenal glomerulosa cells. Am J Physiol 248:1 Pt 1 (1985), E36–E43.
28. Turlapaty, P.D., Altura, B.M., Extracellular magnesium ions control calcium exchange and content of vascular smooth muscle. Eur J Pharmacol 52:3-4 (1978), 421–423.
29. Fischer, P.W., Giroux, A., Effects of dietary magnesium on sodium-potassium pump action in the heart of rats. J Nutr 117:12 (1987), 2091–2095.
30. Wong, N.L., Hu, D.C., Wong, E.F., Effect of dietary magnesium on atrial natriuretic peptide release. Am J Physiol 261:5 Pt 2 (1991), H1353–H1357.
31. Goodman, W.G., Goldin, J., Kuizon, B.D., et al. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 342:20 (2000), 1478–1483.
32. Baia, L.C., Heilberg, I.P., Navis, G., de Borst, M.H., Phosphate and FGF-23 homeostasis after kidney transplantation. Nat Rev Nephrol 11:11 (2015), 656–666.
33. Salem, S., Bruck, H., Bahlmann, F.H., et al. Relationship between magnesium and clinical biomarkers on inhibition of vascular calcification. Am J Nephrol 35:1 (2012), 31–39.
34. Zelt, J.G.E., McCabe, K.M., Svajger, B., et al. Magnesium modifies the impact of calcitriol treatment on vascular calcification in experimental chronic kidney disease. J Pharmacol Exp Ther 355:3 (2015), 451–462.
35. Martinez-Moreno, J.M., Munoz-Castaneda, J.R., Herencia, C., et al. In vascular smooth muscle cells paricalcitol prevents phosphate-induced Wnt/beta-catenin activation. Am J Physiol Renal Physiol 303:8 (2012), F1136–F1144.
36. Montezano, A.C., Zimmerman, D., Yusuf, H., et al. Vascular smooth muscle cell differentiation to an osteogenic phenotype involves TRPM7 modulation by magnesium. Hypertens (Dallas, Tex 1979) 56:3 (2010), 453–462.
37. Hruby, A., O'Donnell, C.J., Jacques, P.F., Meigs, J.B., Hoffmann, U., McKeown, N.M., Magnesium intake is inversely associated with coronary artery calcification: the Framingham heart study. JACC Cardiovasc Imaging 7:1 (2014), 59–69.
38. Keyzer, C.A., de Borst, M.H., van den Berg, E., et al. Calcification propensity and Survival among renal transplant recipients. J Am Soc Nephrol 27:1 (2016), 239–248.
39. Montes de Oca, A., Guerrero, F., Martinez-Moreno, J.M., et al. Magnesium inhibits Wnt/beta-catenin activity and reverses the osteogenic transformation of vascular smooth muscle cells. PLoS One, 9(2), 2014, e89525.
40. Van Laecke, S., Marechal, C., Verbeke, F., et al. The relation between hypomagnesaemia and vascular stiffness in renal transplant recipients. Nephrol Dial Transplant 26:7 (2011), 2362–2369.
41. Joris, P.J., Plat, J., Bakker, S.J., Mensink, R.P., Long-term magnesium supplementation improves arterial stiffness in overweight and obese adults: results of a randomized, double-blind, placebo-controlled intervention trial. Am J Clin Nutr 103:5 (2016), 1260–1266.
42. Laurent, S., Boutouyrie, P., Asmar, R., et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertens (Dallas, Tex 1979) 37:5 (2001), 1236–1241.
43. Vlachopoulos, C., Aznaouridis, K., Stefanadis, C., Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol 55:13 (2010), 1318–1327.
44. Shechter, M., Sharir, M., Labrador, M.J., Forrester, J., Silver, B., Bairey Merz, C.N., Oral magnesium therapy improves endothelial function in patients with coronary artery disease. Circulation 102:19 (2000), 2353–2358.
45. Watson, K.V., Moldow, C.F., Ogburn, P.L., Jacob, H.S., Magnesium sulfate: rationale for its use in preeclampsia. Proc Natl Acad Sci U S A 83:4 (1986), 1075–1078.
46. Weglicki, W.B., Phillips, T.M., Freedman, A.M., Cassidy, M.M., Dickens, B.F., Magnesium-deficiency elevates circulating levels of inflammatory cytokines and endothelin. Mol Cell Biochem 110:2 (1992), 169–173.
47. Iseri, L.T., French, J.H., Magnesium: nature's physiologic calcium blocker. Am Heart J 108:1 (1984), 188–193.
48. Afsar, B., Elsurer, R., The relationship between magnesium and ambulatory blood pressure, augmentation index, pulse wave velocity, total peripheral resistance, and cardiac output in essential hypertensive patients. J Am Soc Hypertens 8:1 (2014), 28–35.
49. Pearson, P.J., Evora, P.R., Seccombe, J.F., Schaff, H.V., Hypomagnesemia inhibits nitric oxide release from coronary endothelium: protective role of magnesium infusion after cardiac operations. Ann Thorac Surg 65:4 (1998), 967–972.
50. Joris, P.J., Plat, J., Bakker, S.J.L., Mensink, R.P., Effects of long-term magnesium supplementation on endothelial function and cardiometabolic risk markers: a randomized controlled trial in overweight/obese adults. Sci Rep, 7(1), 2017, 106.
51. Ridker, P.M., Everett, B.M., Thuren, T., et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med 377:12 (2017), 1119–1131.
52. Song, Y., Li, T.Y., van Dam, R.M., Manson, J.E., Hu, F.B., Magnesium intake and plasma concentrations of markers of systemic inflammation and endothelial dysfunction in women. Am J Clin Nutr 85:4 (2007), 1068–1074.
53. Gommers, L.M.M., Hoenderop, J.G.J., Bindels, R.J.M., de Baaij, J.H.F., Hypomagnesemia in type 2 diabetes: a vicious circle?. Diabetes 65:1 (2016), 3–13.
54. Paolisso, G., Barbagallo, M., Hypertension, diabetes mellitus, and insulin resistance: the role of intracellular magnesium. Am J Hypertens 10:3 (1997), 346–355.
55. Yki-Jarvinen, H., Insulin resistance and endothelial dysfunction. Best Pract Res Clin Endocrinol Metab 17:3 (2003), 411–430.
56. Lostroh, A.J., Krahl, M.E., Insulin action. Accumulation in vitro of Mg 2 + and K + in rat uterus: ion pump activity. Biochim Biophys Acta 291:1 (1973), 260–268.
57. Guerrero-Romero, F., Tamez-Perez, H.E., Gonzalez-Gonzalez, G., et al. Oral magnesium supplementation improves insulin sensitivity in non-diabetic subjects with insulin resistance. A double-blind placebo-controlled randomized trial. Diabetes Metab 30:3 (2004), 253–258.
58. Rodriguez-Moran, M., Guerrero-Romero, F., Oral magnesium supplementation improves insulin sensitivity and metabolic control in type 2 diabetic subjects: a randomized double-blind controlled trial. Diabetes Care 26:4 (2003), 1147–1152.
59. Kieboom, B.C.T., Ligthart, S., Dehghan, A., et al. Serum magnesium and the risk of prediabetes: a population-based cohort study. Diabetologia 60:5 (2017), 843–853.
60. Shimosawa, T., Takano, K., Ando, K., Fujita, T., Magnesium inhibits norepinephrine release by blocking N-type calcium channels at peripheral sympathetic nerve endings. Hypertension 44:6 (2004), 897–902.
61. Lichodziejewska, B., Klos, J., Rezler, J., et al. Clinical symptoms of mitral valve prolapse are related to hypomagnesemia and attenuated by magnesium supplementation. Am J Cardiol 79:6 (1997), 768–772.
62. Binnenmars, S.H., Hijmans, R.S., Navis, G., de Borst, M.H., Biomarkers of renal function: towards clinical actionability. Clin Pharmacol Ther 102:3 (2017), 481–492.